- Trials with a EudraCT protocol (2,936)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,936 result(s) found.
Displaying page 1 of 147.
EudraCT Number: 2017-004506-18 | Sponsor Protocol Number: LYMRIT-37-07 | Start Date*: 2018-06-13 | |||||||||||
Sponsor Name:Nordic Nanovector ASA | |||||||||||||
Full Title: A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1) | |||||||||||||
Medical condition: Follicular lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004978-34 | Sponsor Protocol Number: RBHP2017BACHOUMAS | Start Date*: 2018-12-04 |
Sponsor Name:CHU de Clermont-ferrand | ||
Full Title: Efficacy of Testosterone gel to restore normal serum values of testosterone during the acute phase of critical illness in adult ICU patients. An open-label parallel randomized controlled pilot study | ||
Medical condition: - Hypermetabolism in ICU, loss of muscle mass and functional disability after ICU - ICU acquired hypogonadism - Treatment with testosterone gel in ICU | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004529-17 | Sponsor Protocol Number: YO39609 | Start Date*: 2018-07-17 | ||||||||||||||||
Sponsor Name:F. Hoffman-La Roche Ltd | ||||||||||||||||||
Full Title: A PHASE Ib/II, OPEN-LABEL, MULTICENTER, RANDOMIZED, UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH LOCALLY ADVANCED UNRESE... | ||||||||||||||||||
Medical condition: Locally advanced unresectable or Metastatic gastric or gastroesophageal junction cancer or esophageal cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000875-34 | Sponsor Protocol Number: MM1807 | Start Date*: 2018-05-30 | |||||||||||
Sponsor Name:National Center for Cancer Immune Therapy | |||||||||||||
Full Title: Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids | |||||||||||||
Medical condition: Metastatic melanoma with brain metastasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001440-18 | Sponsor Protocol Number: IACI2016 | Start Date*: 2018-05-30 |
Sponsor Name:university medical center utrecht | ||
Full Title: Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls | ||
Medical condition: cystic fibrosis and healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004564-35 | Sponsor Protocol Number: 205739 | Start Date*: 2018-08-14 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd. | |||||||||||||
Full Title: A Phase IIa Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study to Investigate the Clinical Efficacy, Safety, and Tolerability of Nemiralisib (GSK2269557) in Symptomatic COPD Particip... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD)/chronic bronchitis and emphysema | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) NL (Prematurely Ended) ES (Prematurely Ended) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003008-30 | Sponsor Protocol Number: 16/0730 | Start Date*: 2020-07-01 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled single-site study of high dose simvastatin treatment for secondary progressive multiple sclerosis: impact on vascular perfusion and oxidative damage | |||||||||||||
Medical condition: Multiple Sclerosis (Secondary Progressive) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003943-20 | Sponsor Protocol Number: DX-2930-03 | Start Date*: 2016-03-31 | |||||||||||
Sponsor Name:Dyax Corp., an indirect, wholly-owned subsidiary of Shire plc. | |||||||||||||
Full Title: HELP Study™: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX 2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE) | |||||||||||||
Medical condition: Hereditary angioedema (HAE) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004903-33 | Sponsor Protocol Number: IBM4809 | Start Date*: 2018-06-18 | |||||||||||
Sponsor Name:Orphazyme A/S | |||||||||||||
Full Title: Phase 2/3 Study of Arimoclomol in Inclusion Body Myositis (IBM) A Randomized, Double-blind, Placebo-Controlled Trial | |||||||||||||
Medical condition: Sporadic Inclusion Body Myositis (sIBM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000299-13 | Sponsor Protocol Number: NVD003-CLN01 | Start Date*: 2018-05-17 |
Sponsor Name:Novadip Biosciences | ||
Full Title: A prospective multicentre single-arm study in adults to evaluate the safety and preliminary efficacy of the autologous 3D osteogenic implant NVD-003 for bone reconstruction for the treatment of rec... | ||
Medical condition: Patients with documented recalcitrant lower limb nonunion, meaning a single, meta- and/or diaphyseal nonunion defect of femur or tibia after at least one failed reconstructive surgical attempt. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) LU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000307-17 | Sponsor Protocol Number: 69HCL16_0743 | Start Date*: 2018-07-19 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Microcirculatory and Macrocirculatory Effects of Landiolol on Postoperative Atrial Fibrillation: a Randomized Study. MMELPOAF study. | |||||||||||||
Medical condition: Postoperative Atrial Fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000016-19 | Sponsor Protocol Number: PSCs | Start Date*: 2018-04-04 |
Sponsor Name:Universitair ziekenhuis Brussel | ||
Full Title: Randomized comparative double blind prospective study with hyperbaric prilocaine 2 % and 3 different doses of sufentanil for elective caesarean section. | ||
Medical condition: Healthy pregnant women | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003793-13 | Sponsor Protocol Number: 2017_07 | Start Date*: 2018-03-22 | |||||||||||
Sponsor Name:centre hospitalier et universitaire de Lille | |||||||||||||
Full Title: Arrêt précoce du traitement antifongique empirique en réanimation guidé par dosages sériques de biomarqueurs fongiques : Etude randomisée contrôlée | |||||||||||||
Medical condition: INFECTION INVASIVE A CANDIDA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002076-41 | Sponsor Protocol Number: 0667 | Start Date*: 2018-08-23 | ||||||||||||||||
Sponsor Name:University of Leicester | ||||||||||||||||||
Full Title: A RANDOMISED CONTROLLED TRIAL OF PRE-SURGERY SODIUM VALPROATE, FOR THE PREVENTION OF ORGAN INJURY IN CARDIAC SURGERY: Val-CARD | ||||||||||||||||||
Medical condition: Reduction of myocardial and kidney injury risk of post cardiac surgery by increasing the expression of genes that promote myocardial mitochondrial homeostasis via effects on chromatin histone deace... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004527-67 | Sponsor Protocol Number: DT-DP-DFU-CR-04 | Start Date*: 2018-08-06 |
Sponsor Name:DermaTools Biotech GmbH | ||
Full Title: A Randomised Dose Finding Study Comparing The Safety And Efficacy Of three blinded doses of Diperoxochloric Acid (DPOCl, DermaPro®) and A Standard Moist Wound Dressing In Patients With Non-Healing... | ||
Medical condition: Diabetic foot ulcer with mean diameter between 1.5 and 4 cm after débridement if indicated), Wound stage Wagner grade I or II, Armstrong stadium A or C (for Wagner-Armstrong-Classification), tr... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) EE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000754-35 | Sponsor Protocol Number: R118528 | Start Date*: 2017-07-18 | |||||||||||
Sponsor Name:The University of Manchester | |||||||||||||
Full Title: The effect of Denosumab on Pain and bone Marrow Lesions in symptomatic Knee Osteo-arthritis: A Randomised Double Blind Placebo controlled Clinical Trial | |||||||||||||
Medical condition: Knee osteoarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000019-26 | Sponsor Protocol Number: D5670C00013 | Start Date*: 2018-05-04 | |||||||||||
Sponsor Name:MedImmune Limited, a wholly owned subsidiary of AstraZeneca | |||||||||||||
Full Title: A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MEDI0382 in Subjects with Type 2 Diabetes Mellitus and Renal Impairment | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000156-18 | Sponsor Protocol Number: 301OTC02 | Start Date*: 2018-08-15 | |||||||||||
Sponsor Name:Ultragenyx Pharmaceutical, Inc. | |||||||||||||
Full Title: A Long-Term Follow-up Study to Evaluate the Safety and Efficacy of Adeno-Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Adults with Lat... | |||||||||||||
Medical condition: Ornithine transcarbamylase deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Ongoing) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004745-70 | Sponsor Protocol Number: 55438 | Start Date*: 2018-11-06 |
Sponsor Name:Academic Medical Center (AMC) | ||
Full Title: Efficacy of intranasal ketamine on acute suicidality, a double blind randomized placebo-controlled trial (Ketamine Trial Amsterdam, KETA) | ||
Medical condition: Acute suicidality, which is a rapid increase in suicidal ideation or behaviour from the patient's 'baseline' in the last 24 hours. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004175-31 | Sponsor Protocol Number: Prucalopride2017 | Start Date*: 2018-04-09 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: A placebo-controlled trial with prucalopride for the treatment of typical reflux symptoms in patients with gastro-esophageal reflux disease with incomplete proton pump inhibitor response | ||
Medical condition: refractory gastro-esophageal reflux disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.